NF1 and glioblastoma: In detail, genetic aberrations occur in primary GBM with the following frequencies: 10–18% loss of neurofibromatosis 1 (NF1) gene, 15–25% mutation of PI3K, 3–60% abnormalities in RTK genes and 60–80% activating TERT promoter mutation.